Skip to main content
Sandeep Jain, MD, Ophthalmology, Chicago, IL

SandeepJainMD

Ophthalmology Chicago, IL

Cornea & External Disease

Professor of Ophthalmology, Director of Dry Eye & ocular GVHD Clinic, Department of Ophthalmology & Visual Sciences, University of Illinois College of Medicine

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jain's full profile

Already have an account?

  • Office

    1855 W Taylor St
    Chicago, IL 60612
    Phone+1 312-996-8937
    Fax+1 312-996-7770

Summary

  • Dr. Jain is a National Eye Institute/NIH funded clinician-scientist and is the Director of the Dry Eye and ocular GVHD clinic at University of Illinois at Chicago. He also directs the Translational Biology Laboratory in the Department. His clinical and translational research work has led to numerous publications in professional journals as well as development of drugs that are in phase I/II clinical trials. He is a member of the Editorial Board of leading Journals in Ophthalmology such as Investigative Ophthalmology and Visual Science, Ocular Surface and Scientific Reports. He has been named one of America’s Best Doctors® since 2007 and has received the American Academy of Ophthalmology’s Achievement Award. He has received several awards and recognition, including Departmental Faculty of the Year from UIC and Physician-Scientist Award from Research to Prevent Blindness. He serves as primary mentor on NEI/NIH grants for clinician-scientist career development of junior faculty. Dr. Jain is the founder and chief scientific officer at Advaite LLC, a startup that this focused on the development of innovative pharmaceuticals and healthcare solutions. After receiving his medical degree, Dr. Jain joined the Wilmer Ophthalmological Institute at The Johns Hopkins University as a pre-residency fellow and completed his residency training in Ophthalmology at the Harkness Eye Institute at Columbia University, New York, followed by subspecialty fellowship in Corneal Diseases at the Massachusetts Eye & Ear Infirmary/Harvard Medical School. Dr. Jain joined the Illinois Eye and Ear Infirmary in 2006. He is board certified in ophthalmology.

Clinical Expertise

  • Sjogren's syndrome, Clinical Trials, Translational Research, ocular GVHD Treatment, Dry eye treatment

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 1999 - 2001
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Ophthalmology, 1996 - 1999
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1995 - 1996
  • Johns Hopkins University
    Johns Hopkins UniversityPost-Doctoral Fellowship, Cornea, External Diseases, and Refractive Surgery, 1992 - 1995
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 1989

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2006 - 2026
  • MA State Medical License
    MA State Medical License 2000 - 2007
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • R01 grant Awards National Eye Institute/NIH
  • Faculty of Year UIC College of Medicine, 2015
  • Physician Scientist Award Research to Prevent Blindness, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • UIC Researcher Awarded $10.15M to Develop Antibody-Based Dry Eye Treatment
    UIC Researcher Awarded $10.15M to Develop Antibody-Based Dry Eye TreatmentFebruary 8th, 2021
  • Scientists Develop Dry Eye Treatment Using Human Antibodies
    Scientists Develop Dry Eye Treatment Using Human AntibodiesOctober 16th, 2019
  • New Antibody-Based Eye Drops Show Promising Signs for Treatment of Dry Eye Disease - Market Research Editorials
    New Antibody-Based Eye Drops Show Promising Signs for Treatment of Dry Eye Disease - Market Research EditorialsOctober 14th, 2019
  • Join now to see all

Grant Support

  • Chronic GVHD: Intersecting aspects in Systemic and Ocular DiseaseNational Eye Institute/NIH2016–2022
  • P30 core grant for vision research, Cell & Microbiology CoreNational Eye Institute/NIH2015–2020
  • Innate Immune Aspects of Ocular Surface DiseaseNational Eye Institute/NIH2015–2020
  • Molecular and Cellular Aspects of Corneal Nerve RegenerationNational Eye Institute/NIH2013–2018

Professional Memberships